Hospital Pharmacy - May 2017 - 373

Jacob et al.
17. Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine
extended-release liposome injection for prolonged postsurgical
analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis
Colon Rectum. 2011;54(12):1552-1559.
18. Golf M, Daniels SE, Onel E. A phase 3, randomized, placebocontrolled trial of DepoFoam® bupivacaine (extended-release
bupivacaine local analgesic) in bunionectomy. Adv Ther.
2011;28(9):776-788.
19. Knight RB, Walker PW, Keegan KA, et al. A randomized controlled trial for pain control in laparoscopic urologic surgery:
0.25% bupivacaine versus long-acting liposomal bupivacaine.
J Endourol. 2015;29(9):1019-1024.
20. Baxter R, Bramlett K, Onel E, Daniels S. Impact of local
administration of liposome bupivacaine for postsurgical analgesia on wound healing: a review of data from ten prospective,
controlled clinical studies. Clin Ther. 2013;35(3):312-320.e5.
21. Butz DR, Shenaq DS, Rundell VLM, et al. Postoperative pain
and length of stay lowered by use of Exparel in immediate,
implant-based breast reconstruction. Plast Reconstr Surg Glob
Open. 2015;3(5):e391.
22. Bagsby DT, Ireland PH, Meneghini RM. Liposomal bupivacaine versus traditional periarticular injection for pain control after total knee arthroplasty. J Arthroplasty. 2014;29(8):
1687-1690.
23. Broome CB, Burnikel B. Novel strategies to improve early outcomes following total knee arthroplasty: a case control study of
intra articular injection versus femoral nerve block. Int Orthop.
2014;38(10):2087-2089.
24. White S, Vaughan C, Raiff D, Eward W, Bolognesi M.
Impact of liposomal bupivacaine administration on postoperative pain in patients undergoing total knee replacement.
Pharmacotherapy. 2015;35(5):477-481.
25. Barrington JW, Olugbode O, Lovald S, Ong K, Watson H,
Emerson RH. Liposomal bupivacaine: a comparative study
of more than 1000 total joint arthroplasty cases. Orthop Clin
North Am. 2015;46(4):469-477.

373
26. Domb BG, Gupta A, Hammarstedt JE, Stake CE, Sharp K,
Redmond JM. The effect of liposomal bupivacaine injection
during total hip arthroplasty: a controlled cohort study. BMC
Musculoskelet Disord. 2014;15:310.
27. Emerson RH, Barrington JW, Olugbode O, Lovald S, Watson H,
Ong K. Comparison of local infiltration analgesia to bupivacaine
wound infiltration as part of a multimodal pain program in total
hip replacement. J Surg Orthop Adv. 2015;24(4):235-241.
28. Schroer WC, Diesfeld PG, LeMarr AR, Morton DJ, Reedy ME.
Does extended-release liposomal bupivacaine better control
pain than bupivacaine after TKA? A prospective, randomized
clinical trial. J Arthroplasty. 2015;30(suppl 9):64-67.
29. Collis PN, Hunter AM, Vaughn MDD, Carreon LY, Huang
J, Malkani AL. Periarticular injection after total knee arthroplasty using liposomal bupivacaine vs a modified Ranawat
suspension: a prospective, randomized study. J Arthroplasty.
2016;31(3):633-636.
30. Surdam JW, Licini DJ, Baynes NT, Arce BR. The use of
Exparel (liposomal bupivacaine) to manage postoperative pain
in unilateral total knee arthroplasty patients. J Arthroplasty.
2015;30(2):325-329.
31. Heim EA, Grier AJ, Butler RJ, Bushmiaer M, Queen RM,
Barnes CL. Use of liposomal bupivacaine instead of an epidural can improve outcomes following total knee arthroplasty.
J Surg Orthop Adv. 2015;24(4):230-234.
32. Cien AJ, Penny PC, Horn BJ, Popovich JM, Taunt CJ.
Comparison between liposomal bupivacaine and femoral nerve
block in patients undergoing primary total knee arthroplasty. J
Surg Orthop Adv. 2015;24(4):225-229.
33. Opioid converter, opioid conversions, pain management. http://
globalrph.com/narcoticonv.htm. Accessed January 6, 2017.
34. Opioid dose calculator. http://www.agencymeddirectors.
wa.gov/Calculator/DoseCalculator.htm. Accessed January 6,
2017.
35. Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc.
2010;58(9):1664-1670.


http://www.globalrph.com/narcoticonv.htm http://www.globalrph.com/narcoticonv.htm http://www.agencymeddirectors.wa.gov/Calculator/DoseCalculator.htm http://www.agencymeddirectors.wa.gov/Calculator/DoseCalculator.htm

Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017

Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com